These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33586667)

  • 1. High performance exhaled breath biomarkers for diagnosis of lung cancer and potential biomarkers for classification of lung cancer.
    Long Y; Wang C; Wang T; Li W; Dai W; Xie S; Tian Y; Liu M; Liu Y; Peng X; Liu Y; Zhang Y; Wang R; Li Q; Duan Y
    J Breath Res; 2021 Feb; 15(1):016017. PubMed ID: 33586667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volatile organic compounds in exhaled breath: a promising approach for accurate differentiation of lung adenocarcinoma and squamous cell carcinoma.
    Li X; Shi L; Long Y; Wang C; Qian C; Li W; Tian Y; Duan Y
    J Breath Res; 2024 Aug; 18(4):. PubMed ID: 39019071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis.
    Zhou J; Huang ZA; Kumar U; Chen DDY
    Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observation of nonanoic acid and aldehydes in exhaled breath of patients with lung cancer.
    Callol-Sanchez L; Munoz-Lucas MA; Gomez-Martin O; Maldonado-Sanz JA; Civera-Tejuca C; Gutierrez-Ortega C; Rodriguez-Trigo G; Jareno-Esteban J
    J Breath Res; 2017 Apr; 11(2):026004. PubMed ID: 28440225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exhaled gases online measurements for esophageal cancer patients and healthy people by proton transfer reaction mass spectrometry.
    Zou X; Zhou W; Lu Y; Shen C; Hu Z; Wang H; Jiang H; Chu Y
    J Gastroenterol Hepatol; 2016 Nov; 31(11):1837-1843. PubMed ID: 26996099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perylene diimide-POSS network for semi selective solid-phase microextraction of lung cancer biomarkers in exhaled breath.
    Soufi G; Bagheri H; Yeganeh Rad L; Minaeian S
    Anal Chim Acta; 2022 Mar; 1198():339550. PubMed ID: 35190135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosing Non-Small Cell Lung Cancer by Exhaled Breath Profiling Using an Electronic Nose: A Multicenter Validation Study.
    Kort S; Brusse-Keizer M; Schouwink H; Citgez E; de Jongh FH; van Putten JWG; van den Borne B; Kastelijn EA; Stolz D; Schuurbiers M; van den Heuvel MM; van Geffen WH; van der Palen J
    Chest; 2023 Mar; 163(3):697-706. PubMed ID: 36243060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of cancer through exhaled breath: a systematic review.
    Krilaviciute A; Heiss JA; Leja M; Kupcinskas J; Haick H; Brenner H
    Oncotarget; 2015 Nov; 6(36):38643-57. PubMed ID: 26440312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of profiles of volatile organic compounds in exhaled breath by means of an electronic nose as a proposal for a screening method for breast cancer: a case-control study.
    Díaz de León-Martínez L; Rodríguez-Aguilar M; Gorocica-Rosete P; Domínguez-Reyes CA; Martínez-Bustos V; Tenorio-Torres JA; Ornelas-Rebolledo O; Cruz-Ramos JA; Balderas-Segura B; Flores-Ramírez R
    J Breath Res; 2020 Sep; 14(4):046009. PubMed ID: 32698165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exhaled VOC detection in lung cancer screening: a comprehensive meta-analysis.
    Fan X; Zhong R; Liang H; Zhong Q; Huang H; He J; Chen Y; Wang Z; Xie S; Jiang Y; Lin Y; Chen S; Liang W; He J
    BMC Cancer; 2024 Jun; 24(1):775. PubMed ID: 38937687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calculated indices of volatile organic compounds (VOCs) in exhalation for lung cancer screening and early detection.
    Chen X; Muhammad KG; Madeeha C; Fu W; Xu L; Hu Y; Liu J; Ying K; Chen L; Yurievna GO
    Lung Cancer; 2021 Apr; 154():197-205. PubMed ID: 33653598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
    van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
    Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breath carbonyl compounds as biomarkers of lung cancer.
    Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
    Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
    J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEA, SCC and NSE levels in exhaled breath condensate--possible markers for early detection of lung cancer.
    Zou Y; Wang L; Zhao C; Hu Y; Xu S; Ying K; Wang P; Chen X
    J Breath Res; 2013 Dec; 7(4):047101. PubMed ID: 24185583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaled biomarkers in lung cancer.
    Horváth I; Lázár Z; Gyulai N; Kollai M; Losonczy G
    Eur Respir J; 2009 Jul; 34(1):261-75. PubMed ID: 19567608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exhaled breath analysis in patients with potentially curative lung cancer undergoing surgery: a longitudinal study.
    Herth J; Schmidt F; Basler S; Sievi NA; Kohler M
    J Breath Res; 2024 May; 18(3):. PubMed ID: 38718786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of lung cancer using volatile biomarkers in breath.
    Phillips M; Altorki N; Austin JH; Cameron RB; Cataneo RN; Greenberg J; Kloss R; Maxfield RA; Munawar MI; Pass HI; Rashid A; Rom WN; Schmitt P
    Cancer Biomark; 2007; 3(2):95-109. PubMed ID: 17522431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.